ATE398677T1 - Antigene aus streptococcus pyogenes und zugehörige dna-fragmente - Google Patents

Antigene aus streptococcus pyogenes und zugehörige dna-fragmente

Info

Publication number
ATE398677T1
ATE398677T1 AT01271387T AT01271387T ATE398677T1 AT E398677 T1 ATE398677 T1 AT E398677T1 AT 01271387 T AT01271387 T AT 01271387T AT 01271387 T AT01271387 T AT 01271387T AT E398677 T1 ATE398677 T1 AT E398677T1
Authority
AT
Austria
Prior art keywords
antigens
streptococcus pyogenes
dna fragments
associated dna
streptococcus
Prior art date
Application number
AT01271387T
Other languages
English (en)
Inventor
Denis Martin
Bernard R Brodeur
Josee Hamel
Stephane Rioux
Patrick Rheault
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE398677T1 publication Critical patent/ATE398677T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
AT01271387T 2000-12-21 2001-12-21 Antigene aus streptococcus pyogenes und zugehörige dna-fragmente ATE398677T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21

Publications (1)

Publication Number Publication Date
ATE398677T1 true ATE398677T1 (de) 2008-07-15

Family

ID=22974225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271387T ATE398677T1 (de) 2000-12-21 2001-12-21 Antigene aus streptococcus pyogenes und zugehörige dna-fragmente

Country Status (12)

Country Link
US (5) US7595057B2 (de)
EP (1) EP1343895B1 (de)
JP (1) JP4080876B2 (de)
AT (1) ATE398677T1 (de)
AU (2) AU2002216863B8 (de)
BE (1) BE2021C506I2 (de)
BR (1) BR0116704A (de)
CA (2) CA2789252C (de)
DE (1) DE60134494D1 (de)
ES (1) ES2307564T3 (de)
FR (1) FR21C1005I2 (de)
WO (1) WO2002050107A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE398677T1 (de) * 2000-12-21 2008-07-15 Id Biomedical Corp Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
CA2321106C (en) * 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
GB9807890D0 (en) 1998-04-09 1998-06-10 Actinova Ltd Peptides
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
EP2053126A1 (de) 1998-07-27 2009-04-29 Sanofi Pasteur Limited Pneumokokkenproteine und Nukleinsäuremoleküle
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
AU7227001A (en) * 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens
ATE547527T1 (de) * 2000-10-13 2012-03-15 Id Biomedical Corp Gruppe b streptococcus bvh-a2 und bvh-a3 antigene
EP2189473A3 (de) * 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nukleinsäure und Proteine von Gruppen A und B Streptokokken
ATE398677T1 (de) * 2000-12-21 2008-07-15 Id Biomedical Corp Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
CA2438921C (en) * 2001-02-21 2012-04-10 Shire Biochem Inc. Streptococcus pyogenes polypeptides and corresponding dna fragments
EP1421098A4 (de) * 2001-04-13 2006-03-15 Wyeth Corp Oberflächenproteine von streptococcus pyogenes
CA2453062C (en) * 2001-07-06 2013-04-02 Shire Biochem Inc. Group b streptococcus bvh-a5 antigens and corresponding dna fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
US7262024B2 (en) * 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
WO2004007725A1 (en) * 2002-07-15 2004-01-22 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
JP2008544949A (ja) * 2004-10-08 2008-12-11 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
US8133483B2 (en) * 2005-06-09 2012-03-13 Hansa Medical Ab Method of treating or preventing a disease or condition mediated by pathogenic IgG antibodies
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
JP5722627B2 (ja) * 2007-09-14 2015-05-27 ジェノビス エービー ＦＣガンマ受容体−ＩｇＧ複合体の解離、ならびにＩｇＧの精製および検出のための方法およびキット
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
ES2307564T9 (es) 2021-04-26
FR21C1005I2 (fr) 2022-01-14
AU1686302A (en) 2002-07-01
EP1343895B1 (de) 2008-06-18
US20150017684A1 (en) 2015-01-15
DE60134494D1 (de) 2008-07-31
CA2432525A1 (en) 2002-06-27
US20130136760A1 (en) 2013-05-30
EP1343895A2 (de) 2003-09-17
ES2307564T3 (es) 2008-12-01
US20040097706A1 (en) 2004-05-20
CA2789252C (en) 2016-11-15
BR0116704A (pt) 2003-12-23
US7595057B2 (en) 2009-09-29
AU2002216863B8 (en) 2008-03-20
US20100119507A1 (en) 2010-05-13
WO2002050107A3 (en) 2003-04-10
CA2432525C (en) 2012-11-27
US20160326221A1 (en) 2016-11-10
CA2789252A1 (en) 2002-06-27
US8298551B2 (en) 2012-10-30
US8821895B2 (en) 2014-09-02
FR21C1005I1 (de) 2021-03-26
WO2002050107A2 (en) 2002-06-27
JP2004524014A (ja) 2004-08-12
BE2021C506I2 (de) 2021-05-31
AU2002216863B2 (en) 2008-02-28
JP4080876B2 (ja) 2008-04-23
US9340586B2 (en) 2016-05-17

Similar Documents

Publication Publication Date Title
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
ATE412750T1 (de) Antigen aus streptococcus pyogenes
WO2004030608A3 (en) Nanoemulsion vaccines
DE69938302D1 (de) Neisseria meningitidis antigene und zusammenstellungen
PT1487485E (pt) Adjuvantes de imidazoquinolina para vacinas de adn
MY125202A (en) Vaccine
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
MY159370A (en) Semi-soft-class immunostimulatory oligonucleotides
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
WO2008048344A3 (en) Bacillus anthracis antigens, vaccine compositions, and related methods
NO20030407D0 (no) Silikatformidlet syntese av omorfe silikater og siloksaner og anvendelse avdette
DE60235223D1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
NO20025146L (no) Isolering og karakterisering av csa-operonet (ETEC-CS4 pili) og fremgangsmåter for anvendelse derav
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
AU2002327795A1 (en) Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb)
WO2005013898A3 (en) Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
WO2003059252A3 (en) Use of a novel cell surface protease from group b streptococcus
WO2002079475A3 (en) Streptococcus pyogenes antigens and corresponding dna fragments
WO2002088178A8 (en) Antigens of group b streptococcus and corresponding dna fragments

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties